Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · IEX Real-Time Price · USD
9.21
+0.05 (0.55%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Fennec Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for FENC stock have an average target of 18, which predicts an increase of 95.44% from the current stock price of 9.21.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for FENC stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $17 → $18 | Strong Buy | Maintains | $17 → $18 | +95.44% | Apr 4, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $17 → $18 | Strong Buy | Maintains | $17 → $18 | +95.44% | Mar 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $17 | Strong Buy | Maintains | $18 → $17 | +84.58% | Aug 4, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +95.44% | Jun 21, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $12 → $16 | Buy | Maintains | $12 → $16 | +73.72% | Apr 6, 2023 |
Financial Forecast
Revenue This Year
51.21M
from 21.25M
Increased by 140.95%
Revenue Next Year
72.87M
from 51.21M
Increased by 42.31%
EPS This Year
0.24
from -0.60
EPS Next Year
1.07
from 0.24
Increased by 349.46%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 57.1M | 89.5M | 120.5M | 176.9M | 251.6M |
| Avg | 51.2M | 72.9M | 102.9M | 145.2M | 220.3M |
| Low | 43.0M | 52.4M | 84.4M | 101.0M | 188.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 168.6% | 74.7% | 65.3% | 72.0% | 73.3% |
| Avg | 140.9% | 42.3% | 41.1% | 41.2% | 51.7% |
| Low | 102.6% | 2.4% | 15.8% | -1.8% | 29.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.55 | 1.47 | 2.81 | 4.65 | 5.48 |
| Avg | 0.24 | 1.07 | 2.11 | 3.34 | 5.32 |
| Low | -0.05 | 0.60 | 1.17 | 2.07 | 5.12 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 519.9% | 164.0% | 120.3% | 64.3% |
| Avg | - | 349.5% | 98.1% | 58.0% | 59.6% |
| Low | - | 152.1% | 9.4% | -2.1% | 53.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.